Department of Neurology, National Institute of Neurology and Neurosurgery, La Havana, Cuba.
Global Brain Health Institute, University of California San Francisco, San Francisco, CA, USA.
J Alzheimers Dis. 2021;79(1):85-94. doi: 10.3233/JAD-200985.
Rapid technological advances offer a possibility to develop cost-effective digital cognitive assessment tools. However, it is unclear whether these measures are suitable for application in populations from Low and middle-income countries (LMIC).
To examine the accuracy and validity of the Brain Health Assessment (BHA) in detecting cognitive impairment in a Cuban population.
In this cross-sectional study, 146 participants (cognitively healthy = 53, mild cognitive impairment (MCI) = 46, dementia = 47) were recruited at primary care and tertiary clinics. The main outcomes included: accuracy of the BHA and the Montreal Cognitive Assessment (MoCA) in discriminating between controls and cognitively impaired groups (MCI and dementia) and correlations between the BHA subtests of memory, executive functions, and visuospatial skills and criterion-standard paper-and-pencil tests in the same domains.
The BHA had an AUC of 0.95 (95% CI: 0.91-0.98) in discriminating between controls and cognitively impaired groups (MCI and dementia, combined) with 0.91 sensitivity at 0.85 specificity. In discriminating between control and MCI groups only, the BHA tests had an AUC of 0.94 (95% CI: 0.90-0.99) with 0.71 sensitivity at 0.85 specificity. Performance was superior to the MoCA across all diagnostic groups. Concurrent and discriminant validity analyses showed moderate to strong correlations between the BHA tests and standard paper-and-pencil measures in the same domain and weak correlations with standard measures in unrelated domains.
The BHA has excellent performance characteristics in detecting cognitive impairment including dementia and MCI in a Hispanic population in Cuba and outperformed the MoCA. These results support potential application of digital cognitive assessment for older adults in LMIC.
快速的技术进步为开发具有成本效益的数字认知评估工具提供了可能。然而,目前尚不清楚这些措施是否适用于来自中低收入国家(LMIC)的人群。
检验古巴人群中 Brain Health Assessment(BHA)检测认知障碍的准确性和有效性。
在这项横断面研究中,我们在初级保健和三级诊所招募了 146 名参与者(认知健康者=53 人,轻度认知障碍者(MCI)=46 人,痴呆症者=47 人)。主要结果包括:BHA 和 Montreal Cognitive Assessment(MoCA)在区分认知健康组和认知障碍组(MCI 和痴呆症)中的准确性,以及 BHA 的记忆、执行功能和视空间技能测试与相同领域的标准纸笔测试之间的相关性。
BHA 在区分认知健康组和认知障碍组(MCI 和痴呆症,合并)中的 AUC 为 0.95(95%CI:0.91-0.98),敏感性为 0.91,特异性为 0.85。在仅区分认知健康组和 MCI 组时,BHA 测试的 AUC 为 0.94(95%CI:0.90-0.99),敏感性为 0.71,特异性为 0.85。在所有诊断组中,BHA 的表现均优于 MoCA。同时,在相同领域的标准纸笔测量和不相关领域的标准测量之间,BHA 测试与标准纸笔测量之间的相关性为中度至高度相关,而与不相关领域的标准测量之间的相关性较弱。
BHA 在检测认知障碍方面具有出色的性能特征,包括在古巴的西班牙裔人群中的痴呆症和 MCI,并且优于 MoCA。这些结果支持在 LMIC 中为老年人应用数字认知评估。